Has Baron Lonner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,073,534 in general payments to Baron Lonner, MD across 533 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Baron Lonner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Baron Lonner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Baron Lonner, MD

Orthopedic Surgery · New York, NYNPI 1780657700

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,328,795 of the $2,073,534 with a category attached, or 64.1%. 19 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 39.7% of the total. Reporting peaked in 2020 at $685,556 and has fallen 75.4% since, to $168,953 in 2025. Among orthopedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,073,534in general payments, 2019–2025

Across 533 payments — averaging $3890.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Depuy Synthes Products, Inc.$823K
Zimvie Inc.$341K
Apifix Ltd.$229K
Zimmer Biomet$216K
Medical Device Business Services, Inc.$198K
Highridge Medical LLC$190K
plus $76K from 13 others

$126,000in research payments, 2019–2025

Across 4 payments — averaging $31,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$120K
Zimmer Biomet$6K

What the payments were for

Royalty or licence$1,328,79564%
Consulting fees$435,34321%
Travel & lodging$33,1952%
Food & beverage$11,5091%
Education$8840%
Ownership interest$228,83411%
Other$34,9752%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Depuy Synthes Products, Inc.	95	$823,190
Zimvie Inc.	98	$341,374
Apifix Ltd.	3	$229,334
Zimmer Biomet	106	$215,838
Medical Device Business Services, Inc.	93	$197,600
Highridge Medical LLC	37	$190,123
Orthopediatrics Corp.	5	$34,975
Stryker	16	$20,702
Spineguard, Inc.	4	$8,500
Alphatec Spine, Inc	16	$5,226
Integrity Implants Inc.	18	$3,641
Johnson & Johnson	27	$1,198
Globus Medical	9	$945
Wishbone Medical Inc.	1	$360
Precision Spine, Inc.	1	$289
Medicrea USA, Corp.	1	$150
EBI, LLC	1	$43
Abbott	1	$24
Orthofix Medical, Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,073,534 in reported general payments places this provider in the 95th percentile of 91 orthopedic surgery providers in New York.

See all orthopedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$30,235

Medicare patients

Services billed

113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopedic surgery in New York

Lon WeinerNew York$622K
James GladstoneNew York$260K
Thomas WickiewiczNew York$201K
David EssigNew York$123K
Stephen ObrienNew York$17K
James SloverNew York$13K
Tyler LucasNew York$7K
Afshin RaziNew York$3K
Benjamin RosenstadtNew York$2K
Peter FrelinghuysenNew York$266

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →